OnKure Therapeutics (OKUR) Other Working Capital Changes (2022 - 2026)
OnKure Therapeutics' (OKUR) quarterly Other Working Capital Changes came in at -$140000.0 in Q1 2026, down 7.69% YoY from -$151666.7 in Q1 2025, and down 1.45% on a QoQ basis from -$138000.0 in Q4 2025.
OnKure Therapeutics (OKUR) Other Working Capital Changes (2022 - 2026) Analysis & Trends
OnKure Therapeutics (OKUR) has 5 years of Other Working Capital Changes data on file, last reported at -$140000.0 in Q1 2026.
- Quarterly Other Working Capital Changes fell 7.69% year-over-year to -$140000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$546000.0 (down 51.25% YoY) and the FY2025 annual result came in at -$536000.0, down 90.75% from the prior year.
- Other Working Capital Changes retreated to -$140000.0 in Q1 2026, from -$138000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $3.5 million in Q4 2023 to a low of -$2.4 million in Q4 2024.
- A 5-year average of -$129823.5 and a median of -$281000.0 in 2026 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2023 — Other Working Capital Changes soared 285.86% — and 2024, when it tumbled 169.02%.
- Tracing OKUR's Other Working Capital Changes over 5 years: stood at -$99000.0 in 2022, then soared by 285.86% to $184000.0 in 2023, then sank by 169.02% to -$127000.0 in 2024, then slipped by 8.66% to -$138000.0 in 2025, then dropped by 1.45% to -$140000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$140000.0 (Q1 2026), -$138000.0 (Q4 2025), and -$136000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.54 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.13 Bn | 78.13 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.58 Bn | 60.40 Bn | 1.37 Bn |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.97 Bn | 9.58 Bn | 668.28 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | OnKure Therapeutics | 198.23 Mn | 21.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -136,000.00 |
| Jun 30, 2026 | -136,000.00 |
| Jun 30, 2026 | -136,000.00 |
| Mar 31, 2026 | -140,000.00 |
| Mar 31, 2026 | -140,000.00 |
| Mar 31, 2026 | -140,000.00 |
| Dec 31, 2025 | -138,000.00 |
| Dec 31, 2025 | -138,000.00 |
| Dec 31, 2025 | -138,000.00 |
| Sep 30, 2025 | -136,000.00 |
| Sep 30, 2025 | -136,000.00 |
| Sep 30, 2025 | -136,000.00 |
| Jun 30, 2025 | -132,000.00 |
| Jun 30, 2025 | -132,000.00 |
| Jun 30, 2025 | -132,000.00 |
| Mar 31, 2025 | -130,000.00 |
| Mar 31, 2025 | -130,000.00 |
| Mar 31, 2025 | -130,000.00 |
| Dec 31, 2024 | -127,000.00 |
| Dec 31, 2024 | -127,000.00 |